Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
General Dermatology
Do you feel there is any role for neoadjuvant imatinib in pediatric DFSP with the classic translocation given that surgery can introduce high morbidity.?
Related Questions
How long can a patient with newly diagnosed merkel cell carcinoma wait for wide local excision with sentinel node biopsy?
What is the process for purchasing and billing Medicare for biologics used in the treatment of psoriasis?
Do you always pursue testing for NOD2 mutations when you are suspecting a diagnosis of Blau syndrome?
How would you approach JAK inhibitors in pregnancy?
How soon after stopping oral steroids can patch testing be performed?
What are your preferred alternative biologic agents for Blau Syndrome when anti-TNFα therapies are contraindicated?
What clinical outcomes or measures of success do you prioritize in your patients with ichthyosis?
What treatment would you offer a patient with extensive lymphangioma circumscriptum intermittently covering the entire abdomen?
What are key considerations for using monobenzone for severe vitiligo?
What concentration of TCA is typically used to treat porokeratosis on the arms and legs?
